Journal of Clinical Endocrinology & Metabolism

Papers
(The H4-Index of Journal of Clinical Endocrinology & Metabolism is 49. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Correction to “Clinical Features and Outcome Analysis of Type B Insulin Resistance Syndrome: A Single-Center Study in China”278
Corrigendum to: Targeting Corticotroph HDAC and PI3-Kinase in Cushing Disease180
Adipokines and Transitions in Metabolic Health Over Time: The Atherosclerosis Risk In Communities (ARIC) Study155
Romosozumab Improves Tissue Thickness–Adjusted Trabecular Bone Score in Women With Osteoporosis and Diabetes147
Association Between Urinary Phthalate Metabolites and Sarcopenia in US Adults From NHANES 2011-2018136
Correction to: “Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine”134
Construction of a Simplified Bone Age Assessment Model in Chinese Children Aged 3 to 18 Years126
Insights on Improving Health Insurance Literacy in Diabetes112
Glycemic, Cardiorenal, and Weight Implications on Noninsulin Pharmacotherapy for the Management of Type 2 Diabetes110
Editorial: A Guidebook for Providers on Comprehensive Diabetes Care108
Navigating the Spectrum of 4 Evidence-Based Nutrition Options for Type 2 Diabetes Management104
Incorporating Complementary Therapies Into Diabetes Care102
Effect of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Adolescents With Cystic Fibrosis99
Corrigendum to: “Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline”99
Comprehensive Comparisons of Different Treatments for Active Graves Orbitopathy: A Systematic Review and Bayesian Model–Based Network Meta-Analysis98
Plasma Proteins Predict Kidney Function Trajectories in Type 2 Diabetes87
Does Insulin Work as Good One or Bad One for the Cardiovascular Tissues?81
Response to Letter to the Editor From He et al: “Dasiglucagon in Children With Congenital Hyperinsulinism up to 1 Year of Age: Results From a Randomized Clinical Trial”81
Letter to the Editor From Prickett and Espiner: “Dynamic Response of Musclin, a Myokine, to Aerobic Exercise and Its Interplay With Natriuretic Peptides and Receptor C”81
Anti-Androgen and Aromatase Inhibitor Do Not Enhance Height in Children With CAH80
Fiber Intervention Study in Prader-Willi Syndrome: Insights into Metabolic and Microbiota Shifts75
Secular Trends in Hip Fracture Mortality and Predictors of Mortality From the NSQIP Database71
Branched-Chain Amino Acids and Their Interactions With Lipid Metabolites for Increased Risk of Gestational Diabetes71
Circulating Inflammatory Cytokines and Female Reproductive Diseases: A Mendelian Randomization Analysis68
Progression of PTH Resistance in Autosomal Dominant Pseudohypoparathyroidism Type Ib Due to Maternal STX16 Deletions67
Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects65
Approach to the Patient: Differential Diagnosis of Cystic Sellar Lesions64
Heart Rate Variability and Incident Type 2 Diabetes in General Population63
Gut Microecology May Be Involved in the Pathogenesis of Hashimoto Thyroiditis by Reducing Production of Hydrogen Sulfide62
DXA-based Fat Mass With Risk of Worsening Insulin Resistance in Adolescents: A 9-Year Temporal and Mediation Study61
New Horizons: Next-Generation Insulin Analogues: Structural Principles and Clinical Goals60
Insulin Pump–related Inpatient Admissions in a National Sample of Youth With Type 1 Diabetes59
Approach to the Patient: Youth-Onset Type 2 Diabetes59
Predicting Bilateral Subtypes of Primary Aldosteronism Without Adrenal Vein Sampling: A Systematic Review and Meta-analysis58
Corrigendum to: “Osteogenesis Imperfecta: The Impact of Genotype and Clinical Phenotype on Adiposity and Resting Energy Expenditure”57
Corrigendum to: “Effect of Testosterone Treatment on Bone Microarchitecture and Bone Mineral Density in Men: a 2-Year RCT”56
Correction to: “Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline”55
Association Between Educational Attainment and Thyroid Function: Results From Mendelian Randomization and the NHANES Study55
Correction to “Low Circulating Levels of miR-451a in Girls with Polycystic Ovary Syndrome: Different Effects of Randomized Treatments”54
Body-weight Cycling and Risk of Diabetic Kidney Disease in People With Type 1 Diabetes in the DCCT/EDIC Population53
Correction to: “GLP-1 Receptor Agonists and SGLT-2 Inhibitors as Adjuncts to Insulin in Type 1 Diabetes: Benefits and Concerns”53
Correction to: “Pharmacologic Weight Management in the Era of Adolescent Obesity”53
Corrigendum to: “Phase 3 Trial of a Small-Volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty”53
Correction to: “Associations of Serum Vitamin B6 Status and Catabolism With All-Cause Mortality in Patients With T2DM”53
Correction to “A Low-Frequency APOB p.(Pro955Ser) Variant Contributes to the Severity of/Variability in Familial Hypercholesterolemia”52
Germline- and Somatic-Inactivating FLCN Variants in Parathyroid Cancer and Atypical Parathyroid Tumors51
Approach to the Patient: Management of Parathyroid Diseases Across Pregnancy51
Corrigendum to: “Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline”51
GLP-1 Receptor Agonists and Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials49
Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman49
Effect of Anamorelin, a Ghrelin Receptor Agonist, on Muscle and Bone in Adults With Osteosarcopenia49
0.072588205337524